PF3D7_0613800

PF3D7_0613800 (PfAP2-06B) is a sequence-specific AP2-domain transcription factor of Plasmodium falciparum that governs asexual intraerythrocytic development and erythrocyte invasion through transcriptional control (PMID:41305314). In 3D7 schizonts, ChIP-seq shows it occupies the genomic loci of pfk13 and pfcrt (PMID:39835275), yet conditional knockdown and a K3124R point mutation neither alter parasite sensitivity to artemisinin or quinolines nor change pfk13 or pfcrt expression, establishing that PfAP2-06B is not functionally required for artemisinin or quinoline resistance despite binding these loci (PMID:39835275). Its essential contribution instead lies in intraerythrocytic growth: conditional knockdown produces an asexual blood-stage growth defect and impaired erythrocyte invasion (PMID:41305314), and transcriptomic profiling of the knockdown reveals dysregulation of invasion-related genes during the schizont stage, indicating PfAP2-06B controls invasion indirectly via schizont-stage transcriptional regulation (PMID:41305314). Beyond these findings, the DNA-binding motif, direct target set, and any protein partners of PfAP2-06B have not been characterized in the available corpus.

1. 2025 Medium

   To ask whether PfAP2-06B directly engages known drug-resistance loci, its genome-wide occupancy was mapped, revealing binding at the pfk13 and pfcrt loci and placing this factor at the promoters of resistance-associated genes.

   Evidence ChIP-seq with GFP-tagged PfAP2-06B in P. falciparum 3D7 schizonts

   PMID:39835275

   Open questions at the time

   • Genome-wide binding beyond pfk13/pfcrt and the underlying DNA sequence motif not defined
   • Single lab, no independent replication
   • Occupancy shown only in schizonts, not across the cycle
2. 2025 Medium

   To test whether locus occupancy translates into functional control of drug resistance, orthogonal genetic perturbations showed PfAP2-06B does not confer artemisinin or quinoline resistance, decoupling physical binding from regulatory function at these loci.

   Evidence CRISPR/Cas9 K3124R point mutation and conditional knockdown with drug susceptibility assays in P. falciparum 3D7

   PMID:39835275

   Open questions at the time

   • Why the factor binds pfk13/pfcrt without regulating them remains unexplained
   • Negative result from a single lab
   • Whether binding has any conditional or stress-dependent function untested
3. 2025 Medium

   To define the essential role of PfAP2-06B, conditional knockdown established it as a regulator of asexual growth and erythrocyte invasion, tying the factor to a concrete cellular process.

   Evidence Conditional knockdown followed by growth and invasion assays in P. falciparum

   PMID:41305314

   Open questions at the time

   • Molecular step of invasion affected not resolved
   • Single lab, no independent replication
   • Strain not specified
4. 2025 Medium

   To determine how PfAP2-06B controls invasion, transcriptomics of the knockdown showed dysregulation of invasion-related genes at the schizont stage, indicating the invasion defect arises from transcriptional control rather than a direct structural role.

   Evidence Bulk and single-cell RNA-seq of conditional PfAP2-06B knockdown P. falciparum

   PMID:41305314

   Open questions at the time

   • Direct versus indirect targets not distinguished by integrating with ChIP-seq
   • DNA-binding motif not identified
   • Single lab, no independent replication

• The DNA sequence motif recognized by PfAP2-06B, its genome-wide direct target set, and any protein interaction partners remain undefined.
• No consensus binding motif reported
• ChIP-seq and RNA-seq datasets not integrated to distinguish direct targets
• No interacting proteins or complex membership characterized